Hyperbilirubinemia after extracorporeal circulation surgery: A recent and prospective study

被引:59
作者
An, Yong [1 ]
Xiao, Ying-Bin [1 ]
Zhong, Qian-Jin [1 ]
机构
[1] Third Mil Med Univ, Xin Qiao Hosp, Dept Cardiovasc Surg, Chongqing 400037, Peoples R China
关键词
extracorporeal circulation; open-heart surgery; hyperbilirubinemia; liver function;
D O I
10.3748/wjg.v12.i41.6722
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To clarify the incidence and nature of postoperative hyperbilirubinemia in patients after modern extracorporeal circulation, to analyze possible perioperative risk factors, and to elucidate the clinical significance of postoperative hyperbilirubinemia associated mortality and morbidity. METHODS: Between March 2005 and May 2006, three hundred and eighty six consecutive patients undergoing extracorporeal circulation surgery due to a variety of cardiac lesions were investigated prospectively. The incidence of postoperative hyperbilirubinemia was defined as a serum total bilirubin concentration of more than 51 mu mol/L. Several perioperative parameters were compared by logistic regression between hyperbilirubinemia and non-hyperbilirubinemia patients to determine possible risk factors contributing to postoperative hyperbilirubinemia and mortality. RESULTS: Overall incidence of postoperative hyperbilirubinemia was 25.3% (98/386). In patients with postoperative hyperbilirubinemia, 56.2% reached peak total bilirubin concentration on the first postoperative day, 33.5% on the second day, and 10.3% on the seventh day. Eighty percent of the increase of total bilirubin resulted from an increase of both conjugated and unconjugated bilirubin. Development of postoperative hyperbilirubinemia was associated with a higher mortality (P < 0.01), longer duration of mechanical ventilation (P < 0.05) and longer ICU stay time (P < 0.05). Preoperative total bilirubin concentration, preoperative right atrium pressure, numbers of valves replaced and of blood transfusion requirement were identified as important predictors for postoperative hyperbilirubinemia. CONCLUSION: Early postoperative hyperbilirubinemia after modern extracorporeal circulation is mainly caused by an increase in both conjugated and unconjugated bilirubin, and is associated with a high mortality. Important contributing factors are the preoperative total bilirubin concentration, preoperative severity of right atrial pressure, numbers of valve replacement procedures, and the amount of blood transfusion requirement during and shortly after surgery. We suggest that postoperative hyperbilirubinemia is a multifactorial process, which is caused by both the impaired liver function of bilirubin transport and the increased production of bilirubin from haemolysis. (C) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:6722 / 6726
页数:5
相关论文
共 11 条
[1]
Incidence of gastrointestinal complications in cardiopulmonary bypass patients [J].
Byhahn, C ;
Strouhal, U ;
Martens, S ;
Mierdl, S ;
Kessler, P ;
Westphal, K .
WORLD JOURNAL OF SURGERY, 2001, 25 (09) :1140-1144
[2]
JAUNDICE AFTER OPEN-HEART SURGERY - A PROSPECTIVE-STUDY [J].
CHU, CM ;
CHANG, CH ;
LIAW, YF ;
HSIEH, MJ .
THORAX, 1984, 39 (01) :52-56
[3]
COLLINS JD, 1983, LANCET, V1, P1119
[4]
Clinical outcome after cardiac operations in patients with cirrhosis [J].
Hayashida, N ;
Shoujima, T ;
Teshima, H ;
Yokokura, Y ;
Takagi, K ;
Tomoeda, H ;
Aoyagi, S .
ANNALS OF THORACIC SURGERY, 2004, 77 (02) :500-505
[5]
Lymphatic Cardiac Tamponade after Open-Heart Surgery with Liver Dysfunction [J].
Toshihiro Kawahira ;
Noboru Wakita ;
Hiroya Minami ;
Masahiro Sakata ;
Ikuro Kitano ;
Tsutomu Shida .
The Japanese Journal of Thoracic and Cardiovascular Surgery, 2003, 51 (12) :669-671
[6]
EARLY JAUNDICE AFTER OPEN-HEART SURGERY [J].
LOCKEY, E ;
MCINTYRE, N ;
ROSS, DN ;
BROOKES, E ;
STURRIDGE, MF .
THORAX, 1967, 22 (02) :165-+
[7]
Michalopoulos A, 1997, HEPATO-GASTROENTEROL, V44, P779
[8]
Heart diseases affecting the liver and liver diseases affecting the heart [J].
Naschitz, JE ;
Slobodin, G ;
Lewis, RJ ;
Zuckerman, E ;
Yeshurun, D .
AMERICAN HEART JOURNAL, 2000, 140 (01) :111-+
[9]
Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update [J].
Paparella, D ;
Yau, TM ;
Young, E .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 21 (02) :232-244
[10]
Hepatic failure after cardiopulmonary bypass is unlikely to be isoflurane hepatitis [J].
Wark, HJ .
ANESTHESIOLOGY, 2002, 97 (05) :1323-1323